Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Note: If you experience severe abdominal pain, persistent vomiting, or a complete lack of bowel movements for several days while on a GLP-1 medication, contact your healthcare provider immediately
Users may experience increased energy levels, improved sleep quality, reduced appetite, and enhanced mood
Because elderly patients are more likely to have renal impairment, care should be taken in dose selection, and monitoring renal function is recommended [see Contraindications (4), Use in Specific Populations (8.6)]
Phase 3 data from the TRIUMPH-4 study, released in December of last year, showed 28.7% average body weight loss at the 12 mg dose over 68 weeks
Specifically, retatrutide acts on three receptors: GLP-1, GIP, and glucagon
US$ 27.17
US$ 26.39
US$ 26.32
US$ 20.35
US$ 26.13
US$ 29.53
US$ 27.77
US$ 28.63
US$ 24.22
